|
BioSerenTach is aggressively and globally looking for partners.
We actively look for partners which suffer from bioavailability problem
of API.
BioSerenTach codevelops suitable formulations for API with our DDS technologies. |
BioSerenTach Inc. |
Head office |
Shimizu-cho 389, Nakagyo-ku, Kyoto 604-0874, Japan |
Tel |
075-746-2160 (from abroad 81-75-746-2160)
|
Fax |
075-746-2160 (from abroad 81-75-746-2160) |
Established |
August 1, 2001 |
E-mail |
info@bioserentach.co.jp |
Chairman |
Prof. Kanji Takada, Ph. D. |
President |
Yasuyo Takada |
Capitalization |
¥10,000,000 |
Main Bank |
Kyoto Bank |
|
Copyright BioSerenTach Inc, 2021
|
|